QQ客服 官方微博 反馈留言

	Higher efficacy of 2-week nab-paclitaxel compared to solvent-based paclitaxel in neoadjuvant chemotherapy of triple negative breast cancers
	Wang, J.; Xie, F.; Zhang, L.; Chen, R.; Zhu, Q.; Yin, Z.; You, S.; Jiang, C.; Zha, X.
	2019
卷号	79期号:4
ISSN号	0008-5472
DOI	10.1158/1538-7445.SABCS18-P1-15-23
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6337445
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, J.,Xie, F.,Zhang, L.,et al. Higher efficacy of 2-week nab-paclitaxel compared to solvent-based paclitaxel in neoadjuvant chemotherapy of triple negative breast cancers[J],2019,79(4).
APA	Wang, J..,Xie, F..,Zhang, L..,Chen, R..,Zhu, Q..,...&Zha, X..(2019).Higher efficacy of 2-week nab-paclitaxel compared to solvent-based paclitaxel in neoadjuvant chemotherapy of triple negative breast cancers.,79(4).
MLA	Wang, J.,et al."Higher efficacy of 2-week nab-paclitaxel compared to solvent-based paclitaxel in neoadjuvant chemotherapy of triple negative breast cancers".79.4(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。